Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
A 19-year-old white woman w i t h urticaria, arthrdgias, a n d hepatitis B-associated antigen i n her serum developed a progressive encephalopathy despite only mild hepatic dysfunction. The patient's serum at 4°C produced a cryoprecipitate containing the hepatitis B-associated antigen and its antibody. Serum complement levels were borderline low. A t autopsy, gross and histological examination of t h e brain revealed only mild residual cerebral edema. Indirect immunofluorescent studies of t h e cerebral cortex and choroid plexus showed no evidence of immune complex deposition. T h e patient's progressive encephalopathy may have been related to t h e presence of cryoprecipitable hepatitis B antigen, a relationship not previously reported. ical basis, the hepatitis-associated antigen and t h e development of a n acute encephalopathy. Case ReportA 19-year-old white woman who was comatose and bilaterally decerebrate was seen in the emergency room of Parkland Memorial Hospital. Her history, obtained from the patient's sister, indicated that she had lived with a jaundiced heroin addict until two months before admission and had developed arthralgias and urticaria six weeks previously. An assay for the hepatitis B surface antigen (HBsAg) obtained at that time was positive [4] (Table). Four weeks later the patient developed anorexia, nausea and vomiting, a mild headache, and some neck sriffness. She was irritable, slept most of the day, and continued to have joint pains that required salicylates for relief. O n the morning of admission the patient was found comatose on the floor. Physical examination in the emergency room revealed a pulse of 140 per minute, temperature of 4 V C , and Cheyne-Stokes respirations. She had mild scleral icterus and a normal-sized liver. Rectal examination revealed guaiacpositive stools. O n neurological examination her disc margins were found to be blurred bilaterally, indicating increased intracranial pressure. She had downbeat nystagmus and alternated between decorticate and decerebrate poscuring. The hemoglobin concentration was 1 I .7 gm/dl with a leukocyte count of 6,800 cells/mm3 and a placelet count of 470,000/mm3. H e r serum chemistry, arterial blood gas, and clotting studies were normal except for a direct1indirect bilirubin concentrarion of 7.215 .0 mgidl, serum glutamic oxaloacetic acid transaminase reading above 500 units, and alkaline phosphatase of 160 and 244 units (normal, < 80).The prothrombin time was normal. Arterial and cerebrospinal fluid (CSF) ammonia levels were only minimally elevated. H e r HBsAg in serum remained positive. The patient's serum was also positive for anti-HAA antibody by radioimmunoassay [4-6] (see the Table). The results of serological tests for collagen vascular disease (antinuclear antibody titer, lupus erythematosus cell preparations, serum protein electrophoresis) were negarive. A screen for toxic substances and a salicylate level were both normal. Urinalysis revealed trace proteinuria.Changes observed in a four-vessel intracranial arteriogram were...
A 19-year-old white woman w i t h urticaria, arthrdgias, a n d hepatitis B-associated antigen i n her serum developed a progressive encephalopathy despite only mild hepatic dysfunction. The patient's serum at 4°C produced a cryoprecipitate containing the hepatitis B-associated antigen and its antibody. Serum complement levels were borderline low. A t autopsy, gross and histological examination of t h e brain revealed only mild residual cerebral edema. Indirect immunofluorescent studies of t h e cerebral cortex and choroid plexus showed no evidence of immune complex deposition. T h e patient's progressive encephalopathy may have been related to t h e presence of cryoprecipitable hepatitis B antigen, a relationship not previously reported. ical basis, the hepatitis-associated antigen and t h e development of a n acute encephalopathy. Case ReportA 19-year-old white woman who was comatose and bilaterally decerebrate was seen in the emergency room of Parkland Memorial Hospital. Her history, obtained from the patient's sister, indicated that she had lived with a jaundiced heroin addict until two months before admission and had developed arthralgias and urticaria six weeks previously. An assay for the hepatitis B surface antigen (HBsAg) obtained at that time was positive [4] (Table). Four weeks later the patient developed anorexia, nausea and vomiting, a mild headache, and some neck sriffness. She was irritable, slept most of the day, and continued to have joint pains that required salicylates for relief. O n the morning of admission the patient was found comatose on the floor. Physical examination in the emergency room revealed a pulse of 140 per minute, temperature of 4 V C , and Cheyne-Stokes respirations. She had mild scleral icterus and a normal-sized liver. Rectal examination revealed guaiacpositive stools. O n neurological examination her disc margins were found to be blurred bilaterally, indicating increased intracranial pressure. She had downbeat nystagmus and alternated between decorticate and decerebrate poscuring. The hemoglobin concentration was 1 I .7 gm/dl with a leukocyte count of 6,800 cells/mm3 and a placelet count of 470,000/mm3. H e r serum chemistry, arterial blood gas, and clotting studies were normal except for a direct1indirect bilirubin concentrarion of 7.215 .0 mgidl, serum glutamic oxaloacetic acid transaminase reading above 500 units, and alkaline phosphatase of 160 and 244 units (normal, < 80).The prothrombin time was normal. Arterial and cerebrospinal fluid (CSF) ammonia levels were only minimally elevated. H e r HBsAg in serum remained positive. The patient's serum was also positive for anti-HAA antibody by radioimmunoassay [4-6] (see the Table). The results of serological tests for collagen vascular disease (antinuclear antibody titer, lupus erythematosus cell preparations, serum protein electrophoresis) were negarive. A screen for toxic substances and a salicylate level were both normal. Urinalysis revealed trace proteinuria.Changes observed in a four-vessel intracranial arteriogram were...
Commercial 1251 anti-HBs was processed to yield a sixfold improvement in economy without significant loss of sensitivity or specificity. Additional polystyrene beads were coupled with commercially supplied anti-HBs. The modified assay (Mod-RlA) was compared with commercial RIA, EIA, and RPHA using established HBsAg panels. Mod-RIA was also compared with HEPATEST (RPHA) for screening 71 200 fresh blood donations during an 11 5-month period. Solid-phase sandwich radioimmunoassay (RIA), particularly that marketed by Abbott Laboratories under the name AUSRIA-IT, remains the most reliable screening test for hepatitis B surface antigen (HBsAg) despite the current strong challenge by enzyme immunoassay (EIA).1"2.34 Unfortunately, the price per test of commercial RIA has proved prohibitive for many transfusion centres restricted to the cheaper and less sensitive reverse passive haemagglutination test (RPHA).5 With some types of assay it is possible to reduce costs by using home-made rather than commercial reagents.6 Many transfusion centres have neither the expertise nor the facilities to produce reagents that require specific protein purification with subsequent radiolabelling. In these circumstances the most that can be achieved in economic terms is a reduction in costs accruing from bulk purchase of commercial reagent. This communication presents evidence that the 1251-labelled anti-HBs in the AUSRIA-I1 RIA kit may be quickly, simply, and routinely processed and diluted to provide sufficient reagent for an average of six times as many assays without significant loss of sensitivity or specificity and without necessitating an increase in incubation time. Material and methods REAGENTS AND EQUIPMENT 1 6'5 mm diameter polystyrene beads (white and tinted) are obtainable from the Precision Plastic Ball Company, 3000 North Cicero Avenue, Chicago, Illinois 60641, USA. In the UK these
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.